Alpha Teknova, Inc. (TKNO)
NASDAQ (NMS) NASDAQ (NMS) Primary Summary
Alpha Teknova Raises Outlook After Record Q2 Revenue at Sidoti Conference
Alpha Teknova NASDAQ: TKNO Chief Financial Officer Matt Lowell said the provider of laboratory and bioprocessing reagents is seeing renewed growth, reporting record second-quarter revenue and raising its full-year outlook as biopharma funding and life-science end markets improve.
Alpha Teknova (TKNO) is a Great Momentum Stock: Should You Buy?
Does Alpha Teknova (TKNO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wall Street Analysts Believe Alpha Teknova (TKNO) Could Rally 35.45%: Here's is How to Trade
The mean of analysts' price targets for Alpha Teknova (TKNO) points to a 35.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Alpha Teknova, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 38 | $110 | $213.18 | $103.18 | 93.8% |
 Joseph Castro Nuveen LLC | 14,158 | $69,516 | $95,141.76 | $25,625.76 | 36.86% |
 Bobby Adusumilli SJS Investment Consulting Inc. | 1 | $2.89 | $5 | $2.11 | 73.01% |
 Brian Goldenberg Divisadero Street Capital Management LP | 78,872 | $409,345.68 | $574,976.88 | $165,631.2 | 40.46% |
 Li Peng China Universal Asset Management Co. Ltd. | 8,533 | $66,875.99 | $42,665 | -$24,210.99 | -36.2% |
Alpha Teknova, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Mark Massaro BTIG | 9,184.22 | $59,330.06 | $67,871.38 | $8,541.32 | 14.4% |
Alpha Teknova, Inc. (TKNO) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Alpha Teknova, Inc. ever had a stock split?
Alpha Teknova, Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Stephen Gunstream CEO | NASDAQ (NMS) Exchange | 02080L102 CUSIP |
| US Country | 158 Employees | - Last Dividend | - Last Split | 25 Jun 2021 IPO Date |
Overview
Alpha Teknova, Inc. is a company that plays a significant role in the life sciences sector, offering a broad range of critical reagents crucial for the research, discovery, development, and commercialization of innovative therapies, vaccines, and molecular diagnostics both in the domestic and international markets. Since its inception in 1996, the company has established a substantial presence, headquartered in Hollister, California, and has become a trusted supplier to the pharmaceutical and biotechnology industries, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. is dedicated to supporting the life sciences market by providing high-quality, reliable products essential for the advancement of medical science and healthcare.
Products and Services
- Pre-poured Media Plates - These are essential for cell growth and cloning applications, offering a sterile and convenient solution for researchers conducting cell culture experiments. The pre-poured media plates simplify the preparation process, ensuring consistency and reliability in results.
- Liquid Cell Culture Media and Supplements - Alpha Teknova, Inc. provides a wide range of liquid cell culture media and supplements, which are crucial for the cellular expansion of various cell types. These products help in maintaining the optimal growth conditions, thereby facilitating successful culturing of cells for research and therapeutic use.
- Molecular Biology Reagents - The company offers a comprehensive suite of molecular biology reagents required for sample manipulation, resuspension, and purification. These reagents are vital for analyzing and isolating nucleic acids and proteins, thereby playing a crucial role in molecular biology research and diagnostic test developments.
- Lab Essentials - Alpha Teknova, Inc. provides a variety of chemical formulations that are extensively used in biological research and drug discovery efforts. These lab essentials are crucial for various experimental protocols and processes, assisting scientists in achieving accurate outcomes in their research endeavors.
- Clinical Solutions - Offering custom products tailored for the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits, Alpha Teknova, Inc. caters to the critical needs of clinical development. These clinical solutions are designed to support the seamless transition from research to therapeutic application, ensuring the delivery of innovative treatments and diagnostic approaches.
